Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Silane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103396429B reveals enzymatic synthesis of silicon chiral centers. Achieve >99% ee with mild conditions. Reliable supplier for cost reduction in fine chemical manufacturing.
Patent CN111747978A reveals a rhodium-catalyzed route for silicon-centered chiral silanes. Achieve high enantioselectivity and scalable production for advanced materials.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN114478608A discloses Rh-catalyzed enantioselective silylation. Offers high ee values and novel structures for functional materials and pharma intermediates.
Patent CN115477667B reveals mild organocatalytic route for chiral silanes. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104478919B details iron-catalyzed chiral silane synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN109503645A reveals cobalt-catalyzed asymmetric hydrosilylation for high-purity chiral gem-disilanes, offering cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN107235995B details a cobalt-catalyzed asymmetric hydrosilylation method offering high enantioselectivity and cost reduction in organosilicon manufacturing for global supply chains.